Ignite Creation Date:
2024-05-06 @ 7:51 AM
Last Modification Date:
2024-10-26 @ 11:53 AM
Study NCT ID:
NCT02618200
Status:
COMPLETED
Last Update Posted:
2019-08-28
First Post:
2015-11-27
Brief Title:
Creation of an Image Database for the Development of a Computer Aided Diagnostic CAD System in Patients With Prostate Cancer
Sponsor:
Hospices Civils de Lyon
Organization:
Hospices Civils de Lyon
Study Overview
Official Title:
Creation of a Multimodality Image Database MRI Ultrasound for the Development of a Computer Aided Diagnostic CAD System in Patients With Prostate Cancer
Status:
COMPLETED
Status Verified Date:
2019-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Echo-CAD
Brief Summary:
Prostate cancer is currently detected by ultrasound-guided biopsy Computer-aided diagnostic CAD systems based on multiparametric MRI are now capable of detecting most aggressive cancer foci non-invasively but additional progress is needed for the technique to be accepted in clinical practice We hypothesize that combining MRI and ultrasound imaging can improve the detection of cancerous tumors As a first step in this direction we need to create a database with MR images 3D ultrasound images and corresponding histopathology results in patients treated by radical prostatectomy for prostate cancer This is the purpose of the present study
In a later stage outside the scope of this study we will be learning how to combine these images to best recognize cancerous tumors we will use that knowledge to develop a new CAD system and we will assess the performance of the new CAD We expect this future system to improve the detection of prostate cancer and to reduce the number of patients requiring biopsy
In a later stage outside the scope of this study we will be learning how to combine these images to best recognize cancerous tumors we will use that knowledge to develop a new CAD system and we will assess the performance of the new CAD We expect this future system to improve the detection of prostate cancer and to reduce the number of patients requiring biopsy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None